Tarsus Pharmaceuticals Q1 EPS $(0.16) Beats $(0.33) Estimate, Sales $162.054M Beat $148.422M Estimate

Benzinga Newsdesk www.benzinga.com Positive 86.7%

Neg 0% Neu 0% Pos 86.7%

Comments

No comments yet. Be the first!